ERManI Is a Target of miR-125b and Promotes Transformation Phenotypes in Hepatocellular Carcinoma (HCC)

Shujuan Pan; Xiaoyun Cheng; Hongan Chen; Patricia D. Castro; Michael M. Ittmann; Anne W. Hutson; Susan K. Zapata; Richard N. Sifers

doi:10.1371/journal.pone.0072829

Loading metrics

Open Access

Peer-reviewed

Research Article

ERManI Is a Target of miR-125b and Promotes Transformation Phenotypes in Hepatocellular Carcinoma (HCC)

Shujuan Pan,

Affiliation Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, United States of America
⨯
Xiaoyun Cheng,

Affiliations Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, United States of America, Department of Lymphoma & Myeloma, University of Texas-M D Anderson Cancer Center, Houston, Texas, United States of America
⨯
Hongan Chen,

Affiliations Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, United States of America, Participant in the Baylor College of Medicine Summer Medical and Research Training Program, Baylor College of Medicine, Houston, Texas, United States of America
⨯
Patricia D. Castro,

Affiliation Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, United States of America
⨯
Michael M. Ittmann,

Affiliation Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, United States of America
⨯
Anne W. Hutson,

Affiliation Department of Pediatrics-Gastroenterology, Hepatology & Nutrition, Baylor College of Medicine, Houston, Texas, United States of America
⨯
Susan K. Zapata,

Affiliation Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, United States of America
⨯
Richard N. Sifers

* E-mail: rsifers@bcm.edu

Affiliations Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, United States of America, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America, Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas, United States of America
⨯

ERManI Is a Target of miR-125b and Promotes Transformation Phenotypes in Hepatocellular Carcinoma (HCC)

Shujuan Pan,
Xiaoyun Cheng,
Hongan Chen,
Patricia D. Castro,
Michael M. Ittmann,
Anne W. Hutson,
Susan K. Zapata,
Richard N. Sifers

Published: August 5, 2013
https://doi.org/10.1371/journal.pone.0072829

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Transfection
Is the Subject Area "Transfection" applicable to this article?

Thanks for your feedback.
Hepatocellular carcinoma
Is the Subject Area "Hepatocellular carcinoma" applicable to this article?

Thanks for your feedback.
Small interfering RNA
Is the Subject Area "Small interfering RNA" applicable to this article?

Thanks for your feedback.
MicroRNAs
Is the Subject Area "MicroRNAs" applicable to this article?

Thanks for your feedback.
Glycoproteins
Is the Subject Area "Glycoproteins" applicable to this article?

Thanks for your feedback.
Hepatoma cells
Is the Subject Area "Hepatoma cells" applicable to this article?

Thanks for your feedback.
Quality control
Is the Subject Area "Quality control" applicable to this article?

Thanks for your feedback.
3' UTR
Is the Subject Area "3' UTR" applicable to this article?

Thanks for your feedback.